死骨片1(SQSTM1)單克隆抗體
Monoclonal Antibody to Sequestosome 1 (SQSTM1)
OSIL; PDB3; ZIP3; p62; p62B; p60; A170; Paget Disease Of Bone 3; Oxidative Stress Induced Like; EBI3-associated protein of 60 kDa; Ubiquitin-binding protein p62
- 編號(hào)UMAD198Hu21
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(jià)(克隆號(hào))D19
- Ig亞型 IgG3 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPD198Hu01-死骨片1(SQSTM1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC/IF
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 333 ¥ 777 ¥ 1110 ¥ 2775 ¥ 11100
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
FITC staining on IF; Sample: Human Hela cell; Primary Ab: 20μg/ml Mouse Anti-Human SQSTM1 Antibody Second Ab: 5μg/ml FITC-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu18)
-
DAB staining on IHC-P;
Sample: Human Stomach Tissue;
Primary Ab: 20μg/ml Mouse Anti-Human SQSTM1 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Human Cardiac Muscle Tissue;
Primary Ab: 20μg/ml Mouse Anti-Human SQSTM1 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Human Cerebrum Tissue;
Primary Ab: 20μg/ml Mouse Anti-Human SQSTM1 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Western Blot; Sample: 293T cell lysate Primary Ab: 2μg/ml Mouse Anti-Human SQSTM1 Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
Western Blot; Sample: Human Placenta lysate
Primary Ab: 0.05μg/ml Mouse Anti-Human SQSTM1 Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)SQSTM1的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別SQSTM1。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPD198Hu01 | 死骨片1(SQSTM1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAD198Hu01 | 死骨片1(SQSTM1)多克隆抗體 | WB; IHC; ICC/IF; FCM |
| UMAD198Hu21 | 死骨片1(SQSTM1)單克隆抗體 | WB; IHC; ICC/IF |
| UMAD198Hu24 | 死骨片1(SQSTM1)單克隆抗體 | WB; ICC/IF; FCM |
| UMAD198Hu27 | 死骨片1(SQSTM1)單克隆抗體 | WB |
| UMAD198Hu22 | 死骨片1(SQSTM1)單克隆抗體 | WB; ICC/IF; FCM |
| UMAD198Hu23 | 死骨片1(SQSTM1)單克隆抗體 | WB; ICC/IF |
| UMAD198Hu29 | 死骨片1(SQSTM1)單克隆抗體 | WB |
| UMAD198Hu26 | 死骨片1(SQSTM1)單克隆抗體 | ICC/IF |
| UMAD198Hu25 | 死骨片1(SQSTM1)單克隆抗體 | IHC |
| UFAD198Hu08 | 抗死骨片1(SQSTM1)單克隆抗體 | FCM |
| UFAD198Hu06 | 抗死骨片1(SQSTM1)單克隆抗體 | FCM |
| UFAD198Hu04 | 抗死骨片1(SQSTM1)單克隆抗體 | FCM |
| UFAD198Hu02 | 抗死骨片1(SQSTM1)單克隆抗體 | FCM |
| USED198Hu | 死骨片1(SQSTM1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UMED198Hu | 死骨片1(SQSTM1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMD198Hu | 死骨片1(SQSTM1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| BRIEFINGS IN BIOINFORMATICS | Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19 [33620066] |
| BIOMARKERS OF AUTOPHAGY AND ANTIVIRAL ROLE OF PLACENTA FOR PREDICTING PRETERM DELIVERY IN PATIENTS WITH PRETERM DELIVERY??- [] |
